Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells
Authors:
Open Access
- 23 May 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 30 (2) , 925-932
Abstract
Kaempferol is a natural flavonoid that possesses anti-proliferative and apoptosis-inducing activities in several cancer cell lines. In the present study, we investigated the anti-metastatic activity of kaempferol and its molecular mechanism(s) of action in human osteosarcoma cells. Kaempferol displayed inhibitory effects on the invasion and adhesion of U-2 osteosarcoma (OS) cells in a concentration-dependent manner by Matrigel Transwell assay and cell adhesion assay. Kaempferol also inhibited the migration of U-2 OS cells in a concentration-dependent manner at different treatment time points by wound-healing assay. Additional experiments showed that kaempferol treatment reduced the enzymatic activities and protein levels of matrix metalloproteinase (MMP)-2, MMP-9 and urokinase plasminogen activator (uPA) by gelatin and casein-plasminogen zymography assays and western blot analyses. Kaempferol also downregulated the mRNA levels of MMP-2 and MMP-9 by quantitative PCR analyses. Furthermore, kaempferol was able to reduce the protein phosphorylation of ERK, p38 and JNK by western blotting. By electrophoretic mobility-shift assay (EMSA), we demonstrated that kaempferol decreased the DNA binding activity of AP-1, an action likely to result in the reduced expression of MMP-2, MMP-9 and uPA. Collectively, our data showed that kaempferol attenuated the MAPK signaling pathways including ERK, JNK and p38 and resulted in the decreased DNA binding ability of AP-1, and hence, the downregulation in the expression and enzymatic activities of MMP-2, MMP-9 and uPA, contributing to the inhibition of metastasis of U-2 OS cells. Our results suggest a potential role of kaempferol in the therapy of tumor metastasis of OS.Keywords
This publication has 71 references indexed in Scilit:
- Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activitiesCancer and Metastasis Reviews, 2012
- The Epidemiology of Osteosarcoma2009
- Muramyl tripeptide (mifamurtide) for the treatment of osteosarcomaExpert Review of Anticancer Therapy, 2009
- Molecular Pathogenesis of OsteosarcomaDNA and Cell Biology, 2007
- Osteosarcoma: Basic Science and Clinical ImplicationsOrthopedic Clinics of North America, 2006
- The Biology of Metastases in Pediatric SarcomasThe Cancer Journal, 2005
- Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose MethotrexateJournal of Clinical Oncology, 2005
- Flavonoids-potent and versatile biologically active compounds interacting with cytochromes P450Chemico-Biological Interactions, 2002
- Flavonoids as AntioxidantsJournal of Natural Products, 2000
- OsteosarcomaEuropean Journal of Cancer, 1997